Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$6.8M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 16 most recent Form 4 transactions.
| -43.2% |
| Open the original filing on SEC.gov |
| Jul 9 | BBIO | BridgeBio Pharma, Inc. | MEXER◷ | 17,167 | $16.75 | $287.5K | +76.0% | Open the original filing on SEC.gov |
| Jun 22 | BBIO | BridgeBio Pharma, Inc. | AGRANT◆ | 5,277 | — | — | — | Open the original filing on SEC.gov |
| Jun 22 | BBIO | BridgeBio Pharma, Inc. | AGRANT | 3,990 | — | — | +21.5% | Open the original filing on SEC.gov |
| Mar 4 | BBIO | BridgeBio Pharma, Inc. | MEXER◷◆ | 64,921 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 64,921 | $64.87 | $4.2M | -77.7% | Open the original filing on SEC.gov |
| Mar 4 | BBIO | BridgeBio Pharma, Inc. | MEXER◷ | 64,921 | $8.45 | $548.6K | +349.2% | Open the original filing on SEC.gov |
| Aug 5, 2025 | BBIO | BridgeBio Pharma, Inc. | MEXER◷◆ | 17,167 | — | — | — | Open the original filing on SEC.gov |
| Aug 5, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 17,167 | $49.00 | $841.2K | -48.0% | Open the original filing on SEC.gov |
| Aug 5, 2025 | BBIO | BridgeBio Pharma, Inc. | MEXER◷ | 17,167 | $16.75 | $287.5K | +92.3% | Open the original filing on SEC.gov |
| Jun 20, 2025 | BBIO | BridgeBio Pharma, Inc. | AGRANT◆ | 8,425 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | BBIO | BridgeBio Pharma, Inc. | AGRANT | 6,589 | — | — | +54.9% | Open the original filing on SEC.gov |
| Apr 14, 2025 | BBIO | BridgeBio Pharma, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 14, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 10,000 | $35.00 | $350K | -45.5% | Open the original filing on SEC.gov |
| Apr 14, 2025 | BBIO | BridgeBio Pharma, Inc. | MEXER◷ | 10,000 | $8.45 | $84.5K | +83.3% | Open the original filing on SEC.gov |